Processa Pharmaceuticals (PCSA) Amortization of Deferred Charges (2018 - 2022)
Processa Pharmaceuticals' (PCSA) quarterly Amortization of Deferred Charges came in at $37500.0 in Q4 2022, little changed on a QoQ basis from $37500.0 in Q3 2022.
Processa Pharmaceuticals (PCSA) Amortization of Deferred Charges (2018 - 2022) Analysis & Trends
Processa Pharmaceuticals (PCSA) has 3 years of Amortization of Deferred Charges data on file, last reported at $37500.0 in Q4 2022.
- Quarterly Amortization of Deferred Charges changed N/A year-over-year to $37500.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $115613.0 (changed N/A YoY) and the FY2022 annual result came in at $115613.0, changed N/A from the prior year.
- Amortization of Deferred Charges steadied at $37500.0 in Q4 2022, from $37500.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $154989.0 in Q3 2020 to a low of $1070.0 in Q1 2020.
- A 3-year average of $32577.2 and a median of $34731.0 in 2018 frame the typical range for Amortization of Deferred Charges.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Processa Pharmaceuticals | 5.69 Mn | 5.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 37,500.00 |
| Dec 31, 2022 | 37,500.00 |
| Sep 30, 2022 | 37,500.00 |
| Sep 30, 2022 | 37,500.00 |
| Jun 30, 2022 | 37,500.00 |
| Jun 30, 2022 | 37,500.00 |
| Mar 31, 2022 | 3,113.00 |
| Mar 31, 2022 | 3,113.00 |
| Dec 31, 2020 | 42,771.00 |
| Dec 31, 2020 | 42,771.00 |
| Sep 30, 2020 | 154,989.00 |
| Sep 30, 2020 | 154,989.00 |
| Jun 30, 2020 | 1,070.00 |
| Jun 30, 2020 | 1,070.00 |
| Mar 31, 2020 | 1,070.00 |
| Mar 31, 2020 | 1,070.00 |
| Dec 31, 2018 | 2,228.00 |
| Dec 31, 2018 | 2,228.00 |
| Sep 30, 2018 | 3,723.00 |
| Sep 30, 2018 | 3,723.00 |